NCT01502176 A Retrospective Register Study to Map the Frequency of Short Duration Atrial Fibrillation (AF) Among All Patients Admitted to Roskilde Sygehus in Denmark in 2010 Status UNKNOWN Phase N/A
NCT01502085 Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens Status COMPLETED Phase PHASE1/PHASE2
NCT01500707 Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235) Status WITHDRAWN Phase PHASE1
NCT01500538 A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL) Status TERMINATED Phase PHASE2
NCT01500525 Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children Status COMPLETED Phase N/A
NCT01500382 A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004) Status TERMINATED Phase PHASE1
NCT01499433 Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease Status UNKNOWN Phase PHASE4
NCT01496170 A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1]) Status COMPLETED Phase PHASE1
NCT01494298 Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes Status COMPLETED Phase N/A
NCT01492881 Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT01492582 Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors Status COMPLETED Phase PHASE2
NCT01490138 Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI) Status UNKNOWN Phase N/A
NCT01485614 Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083) Status COMPLETED Phase PHASE3
NCT01483378 Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital Status COMPLETED Phase NA
NCT01480258 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) Status COMPLETED Phase PHASE3